Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages. | Leukemia | 2023 | 37464070 | PubTator, text mining | PubMed |
| RUFY3 regulates endolysosomes perinuclear positioning, antigen presentation and migration in activated phagocytes. | Nat Commun | 2023 | 37463962 | PubTator, text mining | PubMed |
The mirror like expression of genes involved in the FOXO signaling pathway could be effective in the pathogenesis of human lymphotropic virus type 1 (HTLV-1) through disruption of the downstream pathways. | BMC Res Notes | 2023 | 37461070 | PubTator, text mining | PubMed |
| Microfluidic device combining hydrodynamic and dielectrophoretic trapping for the controlled contact between single micro-sized objects and application to adhesion assays. | Lab Chip | 2023 | 37458004 | PubTator, text mining | PubMed |
| Hematopoiesis and Mast Cell Development. | Int J Mol Sci | 2023 | 37445862 | PubTator, text mining | PubMed |
| Identification and Validation of a Metabolism-Related Prognostic Signature Associated with M2 Macrophage Infiltration in Gastric Cancer. | Int J Mol Sci | 2023 | 37445803 | PubTator, text mining | PubMed |
| Influence of Laparoscopic Surgery on Cellular Immunity in Colorectal Cancer: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | 37444491 | PubTator, text mining | PubMed |
| IL6Myc mouse is an immunocompetent model for the development of aggressive multiple myeloma. | Haematologica | 2023 | 37439384 | PubTator, text mining | PubMed |
| Computed tomography radiomics signature via machine learning predicts RRM2 and overall survival in hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435222 | PubTator, text mining | PubMed |
| Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435203 | PubTator, text mining | PubMed |
| Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors. | Front Immunol | 2023 | 37435085 | PubTator, text mining | PubMed |
| Advances in Immunomodulatory Mechanisms of Mesenchymal Stem Cells-Derived Exosome on Immune Cells in Scar Formation. | Int J Nanomedicine | 2023 | 37427367 | PubTator, text mining | PubMed |
| Approaching hemophagocytic lymphohistiocytosis. | Front Immunol | 2023 | 37426667 | PubTator, text mining | PubMed |
| Platelets-related signature based diagnostic model in rheumatoid arthritis using WGCNA and machine learning. | Front Immunol | 2023 | 37426641 | PubTator, text mining | PubMed |
| Identification and elucidation of cross talk between SLAM Family Member 7 (SLAMF7) and Toll-like receptor (TLR) pathways in monocytes and macrophages. | Sci Rep | 2023 | 37420084 | PubTator, text mining | PubMed |
| Spontaneous resolution of cryptogenic organizing pneumonia: Observational study. | Medicine (Baltimore) | 2023 | 37417600 | PubTator, text mining | PubMed |
| Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma. | PLoS One | 2023 | 37405988 | PubTator, text mining | PubMed |
| Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer. | Front Endocrinol (Lausanne) | 2023 | 37404304 | PubTator, text mining | PubMed |
| Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity. | mBio | 2023 | 37404017 | PubTator, text mining | PubMed |
| Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies. | Genes Dis | 2023 | 37396514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=18